Literature DB >> 25648903

Clinical profile, level of affection and therapeutic management of patients with osteoarthritis in primary care: The Spanish multicenter study EVALÚA.

Ana Castaño Carou1, Salvador Pita Fernández2, Sonia Pértega Díaz3, Francisco Javier de Toro Santos4.   

Abstract

OBJECTIVE: To determine the clinical profile, degree of involvement and management in patients with knee, hip or hand osteoarthritis. MATERIAL AND
METHOD: Observational study (health centers from 14 autonomous regions, n=363 primary care physicians), involving patients with clinical and/or radiological criteria for osteoarthritis from the American College of Rheumatology, consecutively selected (n=1,258). Sociodemographic variables, clinical and radiological findings, comorbidity and therapeutic management were analyzed.
RESULTS: Mean age was 68.0±9.5 years old; 77.8% were women and 47.6% obese. Distribution by location was: 84.3% knee, 23.4% hip, 14.7% hands. All patients reported pain. The most frequent radiographic Kellgren-Lawrence grade was stage 3 for knee and hip (42.9% and 51.9%, respectively), and 3 (37.2%) and 2 (34.5%) for hip. Time since onset of osteoarthritis symptoms was 9.4±7.5 years, with a mean age at onset of around 60 years old and a family history of osteoarthritis in 66.0%. The most frequent comorbidities were: hypertension (55.1%), depression/anxiety (24.7%) and gastroduodenal diseases (22.9%). A total of 97.6% of the patients received pharmacological treatment, with oral analgesics (paracetamol) (70.5%) and oral NSAIDs (67.9%) being the most frequent drugs. Bilateral osteoarthritis was present in 76.9% of patients with knee osteoarthritis, 59.3% in hip and 94.7% in hands. Female gender and time since onset were associated with bilateral knee and hip osteoarthritis.
CONCLUSIONS: The profile of the osteoarthritis patient is female, >65 years old, overweight/obese, with comorbidity, frequent symptoms and moderate radiologic involvement. Most of patients had bilateral osteoarthritis, associated with female gender and time since onset of disease. Paracetamol was the most common pharmacological treatment.
Copyright © 2014 Elsevier España, S.L.U. y Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Entities:  

Keywords:  Disease management; Evaluación de los síntomas; Manejo de la enfermedad; Osteoarthritis; Osteoartritis; Signos y síntomas; Signs and symptoms; Symptom assessment

Mesh:

Year:  2015        PMID: 25648903     DOI: 10.1016/j.reuma.2014.12.005

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  4 in total

1.  Posttraumatic Osteoarthritis Damage in Mice: From Histological and Micro-Computed Tomodensitometric Changes to Gait Disturbance.

Authors:  Alban Fouasson-Chailloux; Marc Dauty; Benoit Bodic; Martial Masson; Yves Maugars; Benoit Metayer; Joëlle Veziers; Julie Lesoeur; François Rannou; Jérôme Guicheux; Claire Vinatier
Journal:  Cartilage       Date:  2021-10-25       Impact factor: 3.117

2.  Performance of Ultrasonography Compared to Conventional Radiography for the Diagnosis of Osteoarthritis in Patients With Knee Pain.

Authors:  Martin Brom; Ignacio J Gandino; Johana B Zacariaz Hereter; Marina Scolnik; Florencia B Mollerach; Leandro G Ferreyra Garrott; Josefina Marin; Santiago O Ruta; Javier E Rosa; Ricardo D García-Mónaco; Enrique R Soriano
Journal:  Front Med (Lausanne)       Date:  2020-07-03

3.  The effectiveness of a web-based decision aid for patients with hip osteoarthritis: study protocol for a randomized controlled trial.

Authors:  Lilisbeth Perestelo-Pérez; Yolanda Álvarez-Pérez; Amado Rivero-Santana; Vanesa Ramos-García; Andrea Duarte-Díaz; Alezandra Torres-Castaño; Ana Toledo-Chávarri; Mario Herrera-Perez; José Luis País-Brito; José Carlos Del Castillo; José Ramón Vázquez; Carola Orrego; Pedro Serrano-Aguilar
Journal:  Trials       Date:  2020-08-24       Impact factor: 2.279

4.  Impact of lower limb osteoarthritis on health-related quality of life: A cross-sectional study to estimate the expressed loss of utility in the Spanish population.

Authors:  Jesús Martín-Fernández; Roberto García-Maroto; Amaia Bilbao; Lidia García-Pérez; Blanca Gutiérrez-Teira; Antonio Molina-Siguero; Juan Carlos Arenaza; Vanesa Ramos-García; Gemma Rodríguez-Martínez; Fco Javier Sánchez-Jiménez; Gloria Ariza-Cardiel
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.